Literature DB >> 3485540

Ectopic synthesis of high-Mr calcitonin by the BEN lung carcinoma cell line reflects aberrant proteolytic processing.

J H Riley, M R Edbrooke, R K Craig.   

Abstract

Cloning and nucleotide sequence analysis of the human calcitonin mRNA from the BEN lung carcinoma cell line, a cell line known to secrete high-Mr forms of calcitonin, showed no difference in the coding region at the nucleotide level compared with calcitonin mRNA isolated from medullary thyroid carcinoma which secretes calcitonin monomer. Therefore, the secretion of high-Mr forms of calcitonin reflects the absence or limited activity of proteolytic processing enzymes within the secretory pathway of this cell line. In all other respects, as judged by RNA blotting and S1 mapping, calcitonin/alpha-CGRP expression was identical to that found in medullary thyroid carcinoma, including the differential use of an alternative splice donor site within intron 1. The BEN cell line also produces low levels of alpha-CGRP mRNA and secretes CGRP antigenic determinants. Analysis of plasma CGRP levels in 12 patients with anaplastic lung carcinoma showed elevated levels in 11 of these, suggesting that CGRP may be an important diagnostic marker for this disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485540     DOI: 10.1016/0014-5793(86)81187-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Structure and methylation of the human calcitonin/alpha-CGRP gene.

Authors:  P M Broad; A J Symes; R V Thakker; R K Craig
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

Review 2.  Peptides from the calcitonin genes: molecular genetics, structure and function.

Authors:  L H Breimer; I MacIntyre; M Zaidi
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

3.  Model for alternative RNA processing in human calcitonin gene expression.

Authors:  R A Bovenberg; W P van de Meerendonk; P D Baas; P H Steenbergh; C J Lips; H S Jansz
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

4.  Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.

Authors:  J M Conlon; L Grimelius; L Thim
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

5.  Calcitonin gene-related peptide and its mRNA in pulmonary neuroendocrine cells and ganglia.

Authors:  I M Keith; M Pelto-Huikko; M Schalling; T Hökfelt
Journal:  Histochemistry       Date:  1991

6.  Calcitonin gene-related peptide immunoreactivity in airway epithelial cells of the human fetus and infant.

Authors:  D E Johnson; J D Wobken
Journal:  Cell Tissue Res       Date:  1987-12       Impact factor: 5.249

7.  Orthostatic hypotension and vasodilatory peptides in bronchial carcinoma.

Authors:  M A Gosney; J R Gosney; M Lye
Journal:  J Clin Pathol       Date:  1995-12       Impact factor: 3.411

8.  Peptides and growth factors in small cell lung cancer: production, binding sites, and growth effects.

Authors:  G Bepler; M Rotsch; G Jaques; M Haeder; J Heymanns; G Hartogh; P Kiefer; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  In situ hybridisation and S1 mapping show that the presence of infiltrating plasma cells is associated with poor prognosis in breast cancer.

Authors:  H Parkes; P Collis; A Baildam; D Ralphs; B Lyons; A Howell; R Craig
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.